Myoview 0.23 mg (Tetrofosmin POWDER FOR SOLUTION) 0.23 MG

MYOVIEW 0.23 MG is a pharmaceutical product containing Tetrofosmin, used for diagnostic imaging in cardiac studies. This intravenous powder for solution is designed to help visualize heart function and blood flow.

Strength

0.23 MG

Manufacturer / TM Owner

GE HEALTHCARE CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MYOVIEW 0.23 MG is primarily used in diagnostic imaging to assess myocardial perfusion. It helps in evaluating blood flow to the heart muscle, which can be crucial for diagnosing and managing certain heart conditions. This medication is often used in conjunction with imaging techniques to provide detailed insights into cardiac function.

Side Effects

MYOVIEW 0.23 MG works by being absorbed by the heart muscle, allowing for clear imaging of blood flow. This can help healthcare providers identify areas of the heart that may not be receiving adequate blood supply. The effects are typically observed through imaging studies, providing valuable information for diagnostic purposes.

Precautions & Warnings

MYOVIEW 0.23 MG should be handled with care and administered by healthcare professionals. It is important to follow proper procedures for preparation and administration to ensure safety. Patients should inform their healthcare provider about any allergies or medical conditions before using this medication.

Avoid Interactions

MYOVIEW 0.23 MG may interact with certain medications or substances. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Specific interactions should be evaluated on an individual basis to ensure safe and effective use.

Frequently Asked Questions

MYOVIEW 0.23 MG is used for diagnostic imaging to assess myocardial perfusion and evaluate heart function.

MYOVIEW 0.23 MG is administered intravenously as a powder for solution, prepared and given by healthcare professionals.

MYOVIEW 0.23 MG helps visualize blood flow to the heart muscle, aiding in diagnostic imaging studies.

Yes, MYOVIEW 0.23 MG should be handled and administered by healthcare professionals, and patients should inform their provider about any allergies or medical conditions.

Potential interactions should be discussed with a healthcare provider to ensure safe use.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.